Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.

Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.

Licensed seasonal influenza vaccines induce antibody (Ab) responses against influenza hemagglutinin (HA) that are limited in their ability to protect against different strains of influenza. Cytotoxic T lymphocytes recognizing the conserved internal nucleoprotein (NP) and matrix protein (M1) are capa...

Повний опис

Бібліографічні деталі
Автори:	Mullarkey, C, Boyd, A, van Laarhoven, A, Lefevre, E, Veronica Carr, B, Baratelli, M, Molesti, E, Temperton, N, Butter, C, Charleston, B, Lambe, T, Gilbert, S
Формат:	Journal article
Мова:	English
Опубліковано:	2013

Схожі ресурси

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses
за авторством: Antrobus, R, та інші
Опубліковано: (2014)

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses.
за авторством: Antrobus, R, та інші
Опубліковано: (2014)

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.
за авторством: Lillie, P, та інші
Опубліковано: (2012)

Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine
за авторством: Powell, T, та інші
Опубліковано: (2013)

Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
за авторством: Timothy J Powell, та інші
Опубліковано: (2013-01-01)

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.
за авторством: Berthoud, T, та інші
Опубліковано: (2011)

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.
за авторством: Antrobus, R, та інші
Опубліковано: (2012)

Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.
за авторством: Lambe, T, та інші
Опубліковано: (2013)

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.
за авторством: Richard D Antrobus, та інші
Опубліковано: (2012-01-01)

Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies
за авторством: Cécile Janssen, та інші
Опубліковано: (2022-11-01)

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
за авторством: Martin C. Langenmayer, та інші
Опубліковано: (2023-06-01)

Adenoviral vectors as novel vaccines for influenza.
за авторством: Coughlan, L, та інші
Опубліковано: (2015)

Novel MVA-based vaccine expressing influenza NP and M1 activates cross-reactive T cell responses in human nasopharynx-associated lymphoid tissue (NALT) (conference abstract)
за авторством: Puksuriwong, S, та інші
Опубліковано: (2018)

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine.
за авторством: Lambe, T, та інші
Опубліковано: (2012)

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine
за авторством: Lambe, T, та інші
Опубліковано: (2012)

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
за авторством: Ota, M, та інші
Опубліковано: (2011)

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
за авторством: Ota, M, та інші
Опубліковано: (2011)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
за авторством: Tully, C, та інші
Опубліковано: (2017)

Development of NP-Based Universal Vaccine for Influenza A Viruses
за авторством: Ekramy E. Sayedahmed, та інші
Опубліковано: (2024-02-01)

A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed InaCTivated inflUenza vaccine in adultS aged 65 years and above (INVICTUS): a study protocol
за авторством: Swayze, H, та інші
Опубліковано: (2019)

Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responsesResearch in context
за авторством: David Pattinson, та інші
Опубліковано: (2024-05-01)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
за авторством: Pedro M. Folegatti, та інші
Опубліковано: (2019-03-01)

Uneventful Coadministration of Seasonal Influenza and COVID-19 BNT162b2 Vaccines Two Weeks Post-Influenza Vaccination in an Egg-Allergic Subject: A Case Report
за авторством: Anwar A. Sayed
Опубліковано: (2023-05-01)

Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial
за авторством: Allison R. Thompson, та інші
Опубліковано: (2019-02-01)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
за авторством: Folegatti, P, та інші
Опубліковано: (2019)

Clinical advances in viral-vectored influenza vaccines
за авторством: Sebastian, S, та інші
Опубліковано: (2018)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
за авторством: Saranya Sridhar, та інші
Опубліковано: (2015-04-01)

Clinical Advances in Viral-Vectored Influenza Vaccines
за авторством: Sarah Sebastian, та інші
Опубліковано: (2018-05-01)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
за авторством: Wei Dong, та інші
Опубліковано: (2018-10-01)

Safety of routine childhood vaccine coadministration versus separate vaccination
за авторством: Bauwens, J, та інші
Опубліковано: (2022)

Safety of routine childhood vaccine coadministration versus separate vaccination
за авторством: Simon de Lusignan, та інші
Опубліковано: (2022-09-01)

Preclinical study of immunogenicity of adjuvanted quadrivalent subunit influenza vaccine
за авторством: I. V. Krasilnikov, та інші
Опубліковано: (2022-07-01)

Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine
за авторством: Hua Shi, та інші
Опубліковано: (2024-12-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
за авторством: Arunkumar, G, та інші
Опубліковано: (2019)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
за авторством: McMahon, M, та інші
Опубліковано: (2019)

Influenza and influenza vaccination in children
за авторством: Viorel ALEXANDRESCU, та інші
Опубліковано: (2017-09-01)

Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
за авторством: Irene González-Domínguez, та інші
Опубліковано: (2024-11-01)

Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics
за авторством: Kaori Sano, та інші
Опубліковано: (2018-08-01)

Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines
за авторством: Teresa Hauguel, та інші
Опубліковано: (2024-10-01)

Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.
за авторством: Boyd, A, та інші
Опубліковано: (2013)